CERRITOS, Calif. and LEXINGTON, Mass., July 30, 2024 (GLOBE NEWSWIRE) -- KabaFusion, a nationally recognized leader in home infusion, has been selected by GC Biopharma USA, Inc. as a limited ...

BOSTON, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Novo Holdings, a leading healthcare investment firm, announced that it has signed a definitive agreement to successfully exit its investment in KabaFusion ...

US-based Memorial Hermann Health System has partnered with KabaFusion to offer its home infusion therapy services for individuals with chronic conditions. This collaboration also aims to provide the ...

February 2, 2026 - LEXINGTON, Mass. - KabaFusion (the "Company”), a nationally recognized leader in home and alternative site infusion, and Nautic Partners ("Nautic”) announced today that Nautic has ...

LEXINGTON, Mass., May 19, 2025 (GLOBE NEWSWIRE) -- KabaFusion, a nationally recognized leader in home and alternative site infusion, today announced it has closed on a transaction with Coram pursuant ...

KabaFusion, a nationally recognized leader in home infusion, has been selected by GC Biopharma USA as a limited distribution partner to provide Alyglo (Immune Globulin Intravenous, Human-stwk) 10 per ...

The partnership aims to streamline processes, reduce denials and increase revenue capture for KabaFusion, according to a March 6 CareCloud news release. KabaFusion specializes in providing infusion ...

Novo Holdings acquires KabaFusion from Pritzker Private Capital. KabaFusion's clinician-led management team will remain significant investors in the business alongside Novo Holdings. COPENHAGEN, ...

CERRITOS, Calif.--(BUSINESS WIRE)--KabaFusion in Cerritos, California and their East Coast location, Home Care Services in Edison, New Jersey, announced today that they have both earned Specialty ...

CERRITOS, Calif.--(BUSINESS WIRE)--KabaFusion, a leading provider of home infusion therapies, today announced it will expand its nationwide footprint by opening infusion care pharmacies in locations ...